Multiplikator Forward P/S: CONMED (CNMD)

CONMED Corporation - logo grafis emiten CNMD

The projected P/S ratio correlates with the dynamics of scheduled surgeries and FDA approvals, while 0.60 captures the magnitude of this parameter for CONMED Corporation (CNMD). The development of electrosurgical systems and implants ensures a steady influx of profitable devices. Business resilience is sustained by the synergy between talented engineers and motivated sales managers who receive high bonuses for equipment sales.

conmed.com - Kapitalisasi marang prakiraan pendapatan CNMD (periode 04.07.2022 - 16.11.2026)

Ringkesan rincian data analitis CONMED Corporation (CNMD)

- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
Analisis fundamental perusahaan:CNMD (CONMED Corp.)
Sampel barang CONMED Inc.

CONMED Corporation generates a steady cash flow driven by widespread demand for disposable surgical consumables. The current forward P/S ratio compares market capitalization with expected revenue, determining the degree of optimism currently priced in. The trend of this metric helps identify unjustified premiums for business scalability. An analysis of the trajectory confirms the extent to which the current asset value aligns with the company's actual expansion rates.

Karo sapa CONMED Corporation saingan

Rasio rega marang prakiraan pendapatan Dexcom CGM DXCM|Penumbra Corp (PEN) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Novanta Inc - Multiplikator Forward P/S|HAE (Haemonetics Corporation) - Kapitalisasi marang prakiraan pendapatan|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|PLSE (Pulse Medical) - Multiplikator Forward P/S|InMode Corp (INMD) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S PMI|Multiplikator forward rega marang pendapatan Surmodics, Inc. SRDX|Multiplikator Forward P/S SENS (senseonics.com)|Multiplikator Forward P/S NeuroPace Inc NPCE|TCMD - Rasio rega marang prakiraan pendapatan|SNWV: Rasio rega marang prakiraan pendapatan|Outset Medical Corp (OM) - Rasio rega marang prakiraan pendapatan|SmartVest - Rega forward marang dodolan|LNSR (LENSAR Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep AVITA Medical Inc. RCEL|Rasio rega marang prakiraan pendapatan Profound Medical (PROF)|Baird Medical Corp (BDMD) - Prakiraan rega marang pendapatan|EDAP TMS SA - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bovie Medical APYX|IceCure Medical Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx LUNG|TELA Bio (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corp.)|Rasio rega marang prakiraan pendapatan sensushealthcare.com|Multiplikator forward rega marang pendapatan Zynex, Inc. (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan inspira-technologies.com IINN|Rasio rega marang pendapatan sing dikarepake ICU (SeaStar Medical Holding Corp.)|IRIX: Multiplikator forward rega marang pendapatan|ibs.inc - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|Rega mangsa ngarep marang pendapatan PFSA (Profusa Inc.)|Multiplikator forward rega marang pendapatan SSKN|Rasio rega marang prakiraan pendapatan GCTK|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|Venus Concept - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S NUWE (Nuwellis Corp)|Rega forward marang dodolan AEMD|ASXC - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Avinger, Inc (AVGR)|BSGM: Multiplikator Forward P/S|Cutera (CUTR) - Multiplikator Forward P/S|KNW (Know Labs) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Inari Medical (NARI)|Rasio rega marang prakiraan pendapatan nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical)